KIFFIK EXP™
For the first time there’s a way to continuously collect the diverse molecular signals from interstitial fluid (ISF) to capture what blood misses and to deliver earlier, more accurate insights for pharma, diagnostics & research.

The Only Platform Unlocking ISF for Real-time biomarker monitoring

EXPLORE THE PLATFORM

*KIFFIK EXP & KIFFIK Lab are not not FDA cleared. For investigational use only.

KIFFIK EXP wearable interstitial fluid biosensor

EXPLORE THE PLATFORM

*KIFFIK EXP & KIFFIK Lab are not not FDA cleared. For investigational use only.

Your next breakthrough begins with KIFFIK

What KIFFIK EXP delivers:

Continuous biomarker data

Real-time molecular and pharmacodynamic monitoring from ISF through a non-invasive wearable device. No lab delays, no single-timepoint gaps.

Better Trial Decisions

Earlier visibility into efficacy signals, safety indicators, and patient stratification, supporting faster endpoints and reduced trial risk.

Multi-therapeutic Flexibility

A single platform for oncology, autoimmune, metabolic, neurodegenerative, and other therapeutic areas—scalable from preclinical through post-market.

Why Insterstitial Fluid
changes the game.

Interstitial fluid contains up to 50% unique biomarkers not found in plasma, offering direct insight into drug and immune activity at the tissue level. Unlike blood draws, ISF can be accessed continuously and without disrupting trial workflows.

Learn more about ISF.

Longitudinal biomarker tracking
Real-time PK/PD monitoring
Companion diagnostics development
Remote & decentralized trial models

“If we were able to measure biological target engagement directly in the fluid around the cells, we would boost the pace of discovery.”

Dr. Francesco del Galdo

Professor, Experimental Medicine, Leeds University

Introducing the KIFFIK EXP™ Platform

Our proprietary platform unlocks the diagnostic power of interstitial fluid — easily, safely, and with precision.

Watch to learn more about the KIFFIk Lab.

Trusted by innovators.

Limitless potential.

Global pharma, diagnostics leaders, and research institutions are partnering with KIFFIK to:

Advance clinical trial biomarker monitoring
Develop & integrate companion diagnostics
Expand multi-analyte detection & multiplexing
Accelerate translational biomarker discovery

Schedule a demo

Dermatology: Non-invasive assessment of skin inflammation, disease flares (e.g., eczema, psoriasis), and potentially early indicators of melanoma or other skin cancers

Beauty & Wellness: Real-time monitoring of skin barrier integrity, hydration, oxidative stress, and treatment response for personalized skincare routines

The Only Platform Unlocking ISF for Real-time biomarker monitoring

Your next breakthrough begins with KIFFIK

What KIFFIK EXP delivers:

Continuous biomarker data

Better Trial Decisions

Multi-therapeutic Flexibility

Why Insterstitial Fluidchanges the game.

Longitudinal biomarker tracking

Real-time PK/PD monitoring

Companion diagnostics development

Remote & decentralized trial models

Introducing the KIFFIK EXP™ Platform

Trusted by innovators.

Limitless potential.

Advance clinical trial biomarker monitoring

Develop & integrate companion diagnostics

Expand multi-analyte detection & multiplexing

Accelerate translational biomarker discovery

Navigation

FOLLOW US

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Estradiol (E2)

Luteinizing Hormone (LH)

Progesterone

Follicle-Stimulating Hormone (FSH)

Anti-Müllerian Hormone (AMH)

Hormonal health shouldn’t be a guessing game. With KIFFIK, women can see their cycle, and their care, more clearly than ever before.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Interleukin-6 (IL-6)

S100B (neurotrauma indicator)

Lactate (tissue hypoxia)

D-dimer (coagulation dysfunction)

Myoglobin (muscle damage)

TNF-α (systemic inflammation)

When every second counts, insight can’t wait for the hospital. KIFFIK’s platform is designed to move with the mission — delivering data where it’s needed most.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Prostate-Specific Antigen (PSA)

PCA3 (Prostate Cancer Antigen 3)

Alpha-methylacyl-CoA racemase (AMACR)

Circulating tumor DNA (ctDNA) for mutation profiling

Interleukin-8 (IL-8) and other inflammation markers

Continuous insight without constant disruption, KIFFIK’s platform enables smarter, patient-centered care for prostate cancer across the spectrum of disease.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

IL-6, CRP (inflammatory signaling)

Adiponectin, leptin (metabolic regulation)

VEGF, IL-8 (oncogenic pathways)

S100B, GFAP (neuroinflammatory injury)

Every breakthrough begins with better data. KIFFIK gives researchers a new lens on human biology, continuously, painlessly, and in real time.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Procalcitonin (PCT)

C-reactive protein (CRP)

Interleukin-6 (IL-6)

TNF-α (Tumor Necrosis Factor-alpha)

Lactate

When sepsis moves fast, we have to move faster. KIFFIK’s platform could help detect the warning signs before symptoms spiral.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Interleukin-1α (IL-1α)

Interleukin-8 (IL-8)

TNF-α

MMP-9 (Matrix metalloproteinase-9)

Reactive oxygen species (ROS)

Natural moisturizing factor (NMF) markers

Why Insterstitial Fluid
changes the game.